Results 201 to 210 of about 120,218 (348)
Molecular imprinting for neurology: Materials, applications, and limitations
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma +3 more
wiley +1 more source
An LC-MS/MS-based platform for the quantification of multiple amyloid beta peptides in surrogate cerebrospinal fluid. [PDF]
Oztug M +4 more
europepmc +1 more source
Platelet-generated amyloid beta peptides in Alzheimer's disease and glaucoma. [PDF]
Inyushin M +4 more
europepmc +1 more source
2P066 Structure of amyloid beta peptide in aqueous environment
K. Takano +6 more
openalex +2 more sources
In this review, agents such baicalein, troxerutin, epigallocatechin gallate, quercetin, melatonin, valproic acid, lithium, neurosteroid progesterone, as well as minocycline have been implicated as neuroprotective agents for irradiation‐induced neurological deficits. Also, agents such as glucocorticoids, methylphenidate, vitamin E, bisdemethoxycurcumin,
Seidu A. Richard +2 more
wiley +1 more source
Lymph‐based liquid biopsy: Current progress and future potential
Recent evidence under the revised Starling principle indicates that lymph‐based liquid biopsies may offer superior diagnostic performance over blood‐based counterparts in certain clinical scenarios, such as early‐stage solid tumor detection. Currently, various biomarkers within the lymphatic system show significant diagnostic potential for a range of ...
Dongdong Liu +6 more
wiley +1 more source
Multifocal cortical myoclonus and cerebral amyloid beta -peptide angiopathy
A. J. Larner +5 more
openalex +2 more sources
P2‐141: Association of plasma Amyloid Beta peptides with blood pressure in the elderly [PDF]
Jean‐Charles Lambert +18 more
openalex +1 more source
Plasmonics‐Enhanced Characterization of Cervid PrP (87–114) Fragment Aggregates in Solution
Multimodal nanophotonics platform combining plasmon‐enhanced imaging, label‐free SERS, and optical staining reveals new insights into the aggregation of the cervid PrP (87–114) fragment, an amyloidogenic sequence linked to chronic wasting disease susceptibility.
Shinki Midha +4 more
wiley +1 more source

